AQST
Aquestive Therapeutics IncLoading price…
User-generated discussion. Not investment advice — verify claims against source filings.
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
25,000 shares ($120,500) on 2026-09-15.
Every filing we hold for this issuer; balances as filed.
SVP Regulatory Affairs
Chief Medical Officer
President and CEO
SVP Sales and Marketing
President and CEO
President and CEO
SVP, Operations
SVP, Operations
Chief Innovation/Tech Officer
President and CEO
SVP, Research & Development
Executive Officer
SVP Sales and Marketing
President and CEO
SVP, General Counsel
Vice Chairman
Director
Director
Director
President and CEO
Director
President and CEO
President and CEO
SVP, General Counsel
Executive Officer
SVP, General Counsel
SVP, Chief Financial Officer
President and CEO
SVP, Operations
Executive Officer
SVP, Chief Financial Officer
SVP Regulatory Affairs
SVP, General Counsel
SVP Sales and Marketing
SVP, Operations
President and CEO
SVP, Operations
Chief Medical Officer
Executive Officer
Executive Officer
President and CEO
Executive Officer
SVP, Operations
Chief Medical Officer
SVP, General Counsel
SVP, Research & Development
President and CEO
SVP, Research & Development
Chief Medical Officer
Chief Innovation/Tech Officer
Executive Officer
Chief Innovation/Tech Officer
Chief Innovation/Tech Officer
President and CEO
President and CEO
SVP, Operations
SVP, Operations
SVP, Research & Development
SVP, Chief Financial Officer
SVP, General Counsel
SVP, Research & Development
Chief Innovation/Tech Officer
SVP, Chief Financial Officer
Chief Medical Officer
Executive Officer
SVP Regulatory Affairs
SVP Sales and Marketing
SVP, General Counsel
SVP, Operations
Chief Medical Officer
Director
Vice Chairman
Director
Director
| Insider | Balance | Latest transaction | Stake |
|---|---|---|---|
| Alexander Mark SchobelChief Innovation/Tech Officer | 984.5K | 2024-03-15▼sell50K | — |
| Barber DanielPresident and CEO | 652.3K | 2026-09-15▼sell25K | — |
| Wargacki StephenSVP, Research & Development | 348.1K | 2025-03-09▼sell15.4K | — |
| Toth A. Ernest JrSVP, Chief Financial Officer | 283.5K | 2026-05-05▼sell92.7K | — |
| Kraus Carl N.Chief Medical Officer | 282.5K | 2025-10-15▼sell20.3K | — |
| Boyd PeterExecutive Officer | 281.7K | 2026-05-05▼sell56.8K | — |
| Cioffi MelinaSVP Regulatory Affairs | 274.9K | 2026-03-10▼sell25.3K | — |
| Korczynski SherrySVP Sales and Marketing | 235.7K | 2026-09-09▼sell8.8K | — |
| Braender LoriSVP, General Counsel | 231K | 2026-05-07▼sell135.7K | — |
| Jung CassieSVP, Operations | 204.2K | 2026-05-05▼sell72.7K | — |
| Greenhawt Matthew J.Chief Medical Officer | 52K | 2026-03-09▲buy50K | — |
| Jenkins Abigail L. | 42K | 2025-06-11▲buy42K | — |
| Brown Gregory B.Director | 42K | 2025-06-11▲buy42K | — |
| Cochran JohnVice Chairman | 42K | 2025-06-11▲buy42K | — |
| Marco TagliettiDirector | 42K | 2025-06-11▲buy42K | — |
| Morris Timothy | 42K | 2025-06-11▲buy42K | — |
| Krop JulieDirector | 0 | 2026-06-23▼sell25K | — |
| 50K |
| $4.29 |
| $214.5K |
| 2026-03-09 | Boyd PeterExecutive Officer | ▲buy | 42.5K | $4.29 | $182.3K |
| 2026-03-09 | Korczynski SherrySVP Sales and Marketing | ▲buy | 42.5K | $4.29 | $182.3K |
| 2026-03-09 | Barber DanielPresident and CEO | ▲buy | 523K | $4.29 | $2.24M |
| 2026-03-09 | Braender LoriSVP, General Counsel | ▲buy | 50K | $4.29 | $214.5K |
| 2025-06-11 | Cochran JohnVice Chairman | ▲buy | 42K | $3.41 | $143.2K |
| 2025-06-11 | Morris Timothy | ▲buy | 42K | $3.41 | $143.2K |
| 2025-06-11 | Brown Gregory B.Director | ▲buy | 42K | $3.41 | $143.2K |
| 2025-06-11 | Marco TagliettiDirector | ▲buy | 42K | $3.41 | $143.2K |
| 2025-06-11 | Jenkins Abigail L. | ▲buy | 42K | $3.41 | $143.2K |
| 2025-06-11 | Krop JulieDirector | ▲buy | 42K | $3.41 | $143.2K |
| $5.22 |
| $45.7K |
| 2026-08-17 | Barber DanielPresident and CEO | ▼sell | 25K | $4.29 | $107.3K |
| 2026-07-16 | Barber DanielPresident and CEO | ▼sell | 20.4K | $4.00 | $81.5K |
| 2026-06-23 | Krop JulieDirector | ▼sell | 25K | $5.02 | $125.5K |
| 2026-06-15 | Barber DanielPresident and CEO | ▼sell | 25K | $4.16 | $104K |
| 2026-05-15 | Barber DanielPresident and CEO | ▼sell | 8.3K | $4.29 | $35.4K |
| 2026-05-07 | Braender LoriSVP, General Counsel | ▼sell | 135.7K | $4.23 | $574K |
| 2026-05-05 | Boyd PeterExecutive Officer | ▼sell | 56.8K | $4.18 | $237.3K |
| 2026-05-05 | Braender LoriSVP, General Counsel | ▼sell | 76.1K | $4.18 | $318.3K |
| 2026-05-05 | Toth A. Ernest JrSVP, Chief Financial Officer | ▼sell | 92.7K | $4.18 | $387.3K |
| 2026-05-05 | Barber DanielPresident and CEO | ▼sell | 335.9K | $4.18 | $1.4M |
| 2026-05-05 | Jung CassieSVP, Operations | ▼sell | 72.7K | $4.18 | $304K |
| 2026-03-10 | Boyd PeterExecutive Officer | ▼sell | 29.8K | $4.17 | $124.3K |
| 2026-03-10 | Toth A. Ernest JrSVP, Chief Financial Officer | ▼sell | 58.3K | $4.17 | $242.9K |
| 2026-03-10 | Cioffi MelinaSVP Regulatory Affairs | ▼sell | 25.3K | $4.17 | $105.5K |
| 2026-03-10 | Braender LoriSVP, General Counsel | ▼sell | 40.1K | $4.17 | $167.2K |
| 2026-03-10 | Korczynski SherrySVP Sales and Marketing | ▼sell | 15.7K | $4.17 | $65.6K |
| 2026-03-10 | Jung CassieSVP, Operations | ▼sell | 45.8K | $4.17 | $190.9K |
| 2026-03-10 | Barber DanielPresident and CEO | ▼sell | 180.7K | $4.17 | $753.4K |
| 2025-10-15 | Jung CassieSVP, Operations | ▼sell | 67.6K | $7.01 | $473.7K |
| 2025-10-15 | Kraus Carl N.Chief Medical Officer | ▼sell | 20.3K | $7.00 | $141.9K |
| 2025-10-15 | Boyd PeterExecutive Officer | ▼sell | 10K | $7.00 | $70K |
| 2025-09-26 | Boyd PeterExecutive Officer | ▼sell | 10K | $6.30 | $63K |
| 2025-09-26 | Barber DanielPresident and CEO | ▼sell | 91.3K | $6.03 | $550.8K |
| 2025-09-05 | Boyd PeterExecutive Officer | ▼sell | 15K | $5.30 | $79.5K |
| 2025-09-04 | Jung CassieSVP, Operations | ▼sell | 62.2K | $5.00 | $310.9K |
| 2025-08-09 | Kraus Carl N.Chief Medical Officer | ▼sell | 10.8K | $3.90 | $42.2K |
| 2025-03-09 | Braender LoriSVP, General Counsel | ▼sell | 10.7K | $2.65 | $28.2K |
| 2025-03-09 | Wargacki StephenSVP, Research & Development | ▼sell | 15.4K | $2.65 | $40.9K |
| 2025-03-09 | Barber DanielPresident and CEO | ▼sell | 54K | $2.65 | $143.1K |
| 2025-03-07 | Wargacki StephenSVP, Research & Development | ▼sell | 12.9K | $2.65 | $34.1K |
| 2024-08-09 | Kraus Carl N.Chief Medical Officer | ▼sell | 10.8K | $3.43 | $37.1K |
| 2024-03-15 | Alexander Mark SchobelChief Innovation/Tech Officer | ▼sell | 50K | $6.00 | $300K |
| 2024-03-09 | Boyd PeterExecutive Officer | ▼sell | 8.4K | $4.88 | $40.8K |
| 2024-03-09 | Alexander Mark SchobelChief Innovation/Tech Officer | ▼sell | 9.6K | $4.88 | $47.1K |
| 2024-03-09 | Alexander Mark SchobelChief Innovation/Tech Officer | ▼sell | 5.9K | $4.88 | $28.8K |
| 2024-03-09 | Barber DanielPresident and CEO | ▼sell | 56.8K | $4.88 | $277.3K |
| 2024-03-09 | Barber DanielPresident and CEO | ▼sell | 37.9K | $4.88 | $185.1K |
| 2024-03-09 | Jung CassieSVP, Operations | ▼sell | 8.3K | $4.88 | $40.5K |
| 2024-03-09 | Jung CassieSVP, Operations | ▼sell | 14.1K | $4.88 | $68.9K |
| 2024-03-09 | Wargacki StephenSVP, Research & Development | ▼sell | 11.3K | $4.88 | $55K |
| 2024-03-09 | Toth A. Ernest JrSVP, Chief Financial Officer | ▼sell | 11.7K | $4.88 | $57.1K |
| 2024-03-09 | Braender LoriSVP, General Counsel | ▼sell | 10.5K | $4.88 | $51.4K |
| 2024-03-09 | Wargacki StephenSVP, Research & Development | ▼sell | 19.5K | $4.88 | $95.2K |
| 2024-03-08 | Alexander Mark SchobelChief Innovation/Tech Officer | ▼sell | 25K | $5.19 | $129.8K |
| $3.10 |
| $77.5K |
| 2025-09-04 | Jung CassieSVP, Operations | option_exercise | 25K | $3.15 | $78.8K |